| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	October Revenue Grew 32% MoM and on Track to hit $10 Million in Monthly Revenue by December 2025 ~ Prenetics Global Limited (NA...
																	Additional Bitcoin Acquisition Follows Immediately on $44 Million Equity OfferingCompany now holds a total of 378 BTC (valued a...
																	Cantor Fitzgerald analyst Ross Osborn maintains Prenetics Global (NASDAQ:PRE) with a Overweight and raises the price target ...
																	
																	
																	Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company, today ...